- Home
- TRDA vs KNOP Comparison
TRDA vs KNOP Comparison
Compare TRDA & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- KNOP
- Stock Information
- Founded
- TRDA 2016
- KNOP 2013
- Country
- TRDA United States
- KNOP United Kingdom
- Employees
- TRDA N/A
- KNOP N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- KNOP Marine Transportation
- Sector
- TRDA Health Care
- KNOP Consumer Discretionary
- Exchange
- TRDA Nasdaq
- KNOP Nasdaq
- Market Cap
- TRDA 264.5M
- KNOP 244.9M
- IPO Year
- TRDA 2021
- KNOP 2013
- Fundamental
- Price
- TRDA $6.64
- KNOP $6.94
- Analyst Decision
- TRDA Strong Buy
- KNOP
- Analyst Count
- TRDA 3
- KNOP 0
- Target Price
- TRDA $25.67
- KNOP N/A
- AVG Volume (30 Days)
- TRDA 127.9K
- KNOP 71.2K
- Earning Date
- TRDA 08-12-2025
- KNOP 09-02-2025
- Dividend Yield
- TRDA N/A
- KNOP 1.49%
- EPS Growth
- TRDA N/A
- KNOP N/A
- EPS
- TRDA 0.61
- KNOP 0.19
- Revenue
- TRDA $172,220,000.00
- KNOP $320,026,000.00
- Revenue This Year
- TRDA N/A
- KNOP $9.28
- Revenue Next Year
- TRDA N/A
- KNOP N/A
- P/E Ratio
- TRDA $10.80
- KNOP $37.02
- Revenue Growth
- TRDA 5.74
- KNOP 8.76
- 52 Week Low
- TRDA $6.12
- KNOP $5.28
- 52 Week High
- TRDA $21.79
- KNOP $7.72
- Technical
- Relative Strength Index (RSI)
- TRDA 47.73
- KNOP 49.93
- Support Level
- TRDA $6.18
- KNOP $6.89
- Resistance Level
- TRDA $6.67
- KNOP $7.46
- Average True Range (ATR)
- TRDA 0.34
- KNOP 0.20
- MACD
- TRDA 0.04
- KNOP -0.04
- Stochastic Oscillator
- TRDA 66.67
- KNOP 13.16
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.